TRICUSPID REPAIR AT THE TIME OF LVAD IMPLANTATION IS ASSOCIATED WITH IMPROVED SURVIVAL  by Atrache, Mazen El et al.
Heart Failure
E881
JACC March 27, 2012
Volume 59, Issue 13
TRICUSPID REPAIR AT THE TIME OF LVAD IMPLANTATION IS ASSOCIATED WITH IMPROVED SURVIVAL
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Monday, March 26, 2012, 9:30 a.m.-10:30 a.m.
Session Title: Mechanical Circulatory Support: Innovations and Outcomes
Abstract Category: 13. Heart Failure: Therapy
Presentation Number: 1212-20
Authors: Mazen El Atrache, Robert Brewer, Hassan Nemeh, Celeste Williams, Cristina Tita, Gaetano Paone, Yelena Selektor, Mauricio Velez, Jeffrey 
Morgan, David Lanfear, Henry Ford Health System, Detroit, MI, USA
Background: Right ventricular failure (RVF) can complicate Left Ventricular Assist Device (LVAD) therapy and is associated with greater mortality. 
Whether tricuspid valve repair (TVR) can reduce these risks is unknown.
Methods: We identified patients undergoing initial implantation of long-term continuous flow LVAD at our institution from 3/2006 to 8/2011 
(N=101). Patients were classified as having RVF if they required an RVAD during hospitalization or inotropic support >1 week. We assessed the 
impact of TVR on survival and incidence of RVF using Kaplan-Meier survival curves, Cox regression, and logistic regression, adjusted for age, gender, 
tricuspid regurgitation (TR), RV function, creatinine, albumin, and indication (bridge vs. destination).
Results: A total of 14 patients underwent TVR at time of LVAD all having moderate or severe TR (n=10 with severe). KM survival estimates did not 
statistically differ by TVR (Figure, p=NS), but after adjustment for confounders, TVR showed a near significant association with improved survival 
(HR=0.1, p=0.074). TVR showed a univariate trend towards RVF (OR=1.77, p=0.43), but after adjustment trended towards a reduced risk of RVF 
(OR=0.68, p=0.7), particularly in patients surviving to hospital discharge (OR=0.29, p=0.28).
Conclusions: Tricuspid valve repair at the time of LVAD implantation is associated with improved survival and trends towards less RVF. More data 
is needed to determine the effect of TVR at the time of LVAD implantation.
